Laura Belvederesi

Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients

Mario Scartozzi, Riccardo Giampieri, Elena Maccaroni et al. · British Journal of Cancer · 2012 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients

Chiara Braconi, R. Bracci, Italo Bearzi et al. · Annals of Oncology · 2008 · 86 citations

Medicine, Endocrinology, Oncology +7

The Role of LDH Serum Levels in Predicting Global Outcome in HCC Patients Undergoing TACE: Implications for Clinical Management

Mario Scartozzi, Luca Faloppi, Maristella Bianconi et al. · PLoS ONE · 2012 · 58 citations · Full text

Medicine, Hematology, Oncology +16

Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with clinical, genetic and functional features

Laura Belvederesi, Francesca Bianchi, Cristian Loretelli et al. · European Journal of Human Genetics · 2006 · 36 citations

Life Sciences, Genetics, Molecular Genetics +14

CAT25 Is a Mononucleotide Marker to Identify HNPCC Patients

Francesca Bianchi, Romina Catalani, Laura Belvederesi et al. · Journal of Molecular Diagnostics · 2009 · 35 citations · Full text

Life Sciences, Genetics, Molecular Genetics +7